XML 44 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings per share (Tables)
3 Months Ended
Apr. 01, 2023
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share
The following table sets forth the computation of basic and diluted loss per share of Class A common stock for the periods presented (amounts in thousands, except share and per share data):
Three Months Ended
April 1, 2023April 2, 2022
Numerator:
Net (loss) income from continuing operations, net of tax$(100,018)$(14,405)
Net loss attributable to noncontrolling interests — continuing operations20,360 3,529 
Net loss attributable to Bioventus Inc. Class A common stockholders —
    continuing operations
$(79,658)$(10,876)
Numerator:
Net (loss) income from discontinued operations, net of tax$(74,429)$(401)
Net loss attributable to noncontrolling interests — discontinued operations14,937 — 
Net loss attributable to Bioventus Inc. Class A common stockholders —
    discontinued operations
$(59,492)$(401)
Denominator:
Weighted-average shares of Class A common stock outstanding - basic and diluted62,124,752 60,484,969 
Net loss per share of Class A common stock from continuing operations, basic and diluted$(1.28)$(0.18)
Net loss per share of Class A common stock from discontinued operations, basic and diluted(0.96)(0.01)
Net loss per share of Class A common stock, basic and diluted$(2.24)$(0.19)
Schedule of Antidilutive Securities
The following number of weighted-average potentially dilutive shares as of April 1, 2023 and April 2, 2022 were excluded from the calculation of diluted loss per share because the effect of including such potentially dilutive shares would have been antidilutive upon conversion:
Three Months Ended
April 1, 2023April 2, 2022
LLC Interests held by Continuing LLC Owner(a)
15,786,737 15,786,737 
Stock options8,517,045 8,757,706 
RSUs1,070,105 462,404 
Total25,373,887 25,006,847 
(a)Class A Shares reserved for future issuance upon redemption or exchange of LLC Interests by the Continuing LLC Owner.